Clincosm LogoSign in Get a demo

Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02401763
Collaborator
(none)
200
Enrollment

Study Details

Study Description

Brief Summary

Nasopharyngeal carcinoma (NPC) is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    NPC is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Time Perspective:
    Retrospective
    Official Title:
    Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
    Study Start Date :
    Apr 1, 2015
    Anticipated Primary Completion Date :
    Apr 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Nasopharyngeal carcinoma and salivary gland tumor

    patients diagnosed and treated in National Taiwan University Hospital

    Outcome Measures

    Primary Outcome Measures

    1. The difference of expression level of mucin glycosylating enzymes (by immunohistochemistry) in nasopharyngeal carcinoma and salivary gland tissues [1~5 years after patients received definite therapy]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • NPC and salivary gland tumor diagnosed and treated in HTUH
    Exclusion Criteria:
    • previous treatment or surgery

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Pei-Jen Lou, NTUH

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT02401763
    Other Study ID Numbers:
    • 201412126RIND
    First Posted:
    Mar 30, 2015
    Last Update Posted:
    Apr 3, 2015
    Last Verified:
    Mar 1, 2015
    Keywords provided by National Taiwan University Hospital
    biomarker
    Additional relevant MeSH terms:
    Carcinoma
    Nasopharyngeal Carcinoma
    Salivary Gland Neoplasms

    Study Results

    No Results Posted as of Apr 3, 2015